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O B J E C T I V E S The aim of the current study is to test the ability to label and detect murine
embryonic stem cell–derived cardiovascular progenitor cells (ES-CPC) with cardiac magnetic resonance
(CMR) using the novel contrast agent Gadoﬂuorine M-Cy3 (GdFM-Cy3).
B A C KG ROUND Cell therapy shows great promise for the treatment of cardiovascular disease. An
important limitation to previous clinical studies is the inability to accurately identify transplanted cells.
GdFM-Cy3 is a lipophilic paramagnetic contrast agent that contains a perﬂuorinated side chain and an
amphiphilic character that allows for micelle formation in an aqueous solution. Previous studies reported
that it is easily taken up and stored within the cytosol of mesenchymal stem cells, thereby allowing for
paramagnetic cell labeling. Investigators in our laboratory have recently developed techniques for the
robust generation of ES-CPC. We reasoned that GdFM-Cy3 would be a promising agent for the in vivo
detection of these cells after cardiac cell transplantation.
METHOD S ES-CPC were labeled with GdFM-Cy3 by incubation. In vitro studies were performed to
assess the impact of GdFM-Cy3 on cell function and survival. A total of 500,000 GdFM-Cy3–labeled
ES-CPC or control ES-CPC were injected into the myocardium of mice with and without myocardial
infarction. Mice were imaged (9.4-T) before and over a 2-week time interval after stem cell transplan-
tation. Mice were then euthanized, and their hearts were sectioned for ﬂuorescence microscopy.
R E S U L T S In vitro studies demonstrated that GdFM-Cy3 was easily transfectable, nontoxic, stayed
within cells after labeling, and could be visualized using CMR and ﬂuorescence microscopy. In vivo
studies conﬁrmed the efﬁcacy of the agent for the detection of cells transplanted into the hearts of mice
after myocardial infarction. A correspondence between CMR and histology was observed.
CONC L U S I O N S The results of the current study suggest that it is possible to identify and
potentially track GdFM-Cy3–labeled ES-CPC in murine infarct models via CMR. (J Am Coll Cardiol Img
2009;2:1114–22) © 2009 by the American College of Cardiology Foundation
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1115eplacement of injured tissue using trans-
planted exogenous cells has shown therapeu-
tic promise in a wide array of conditions,
including spinal cord injury (1), diabetes
ellitus (2,3), stroke (4), and cardiovascular disease
5,6). An important limitation to previous clinical
tudies is the inability to accurately identify trans-
lanted cells. Recent work by our laboratory has
esulted in the identification of embryonic stem cell
ES)-derived cardiovascular progenitor cells (ES-
PC) (7), which we speculate would be promising
gents for cell therapy. Given that the mechanism
See page 1123
nd efficacy of cardiac cell therapy remains uncer-
ain, developing techniques for tracking trans-
lanted cells within the myocardium would be
articularly useful.
Thus far, cardiac magnetic resonance (CMR) has
een a principal diagnostic modality for cell iden-
ification post-transplantation (8,9). Cell identifica-
ion has been facilitated largely through the use of
agnetic resonance (MR) contrast agents that are
ensitive, nontoxic, and remain within cells after
ransplant (10). The 2 classes of MR contrast agents
ost widely used are iron oxides and gadolinium
helates. Superparamagnetic iron oxide nanopar-
icles (SPION) have been used across a broad
pectrum of cell-labeling applications (11–15). Al-
hough iron-labeled cells are highly effective in
enerating MR signal loss, it is often difficult to
ifferentiate the signal loss generated by iron-laden
ells from endogenous sources of signal attenuation
13–16). Gadolinium chelates differ from SPION
n their ability to generate increased MR signal
ntensity when T1-weighted sequences are em-
loyed. Most agents are hydrophilic and have dif-
culty traversing cell membranes. The most widely
sed is gadopentetate dimeglumine (Gd-DTPA),
hich can be used for noninvasive angiography and
o identify areas of perfusion deficit in the myocar-
ium post-infarct (17–19).
Unlike Gd-DTPA, Gadofluorine M (GdFM)
ontains a perfluorinated side chain and an am-
hiphilic character, resulting in micelle formation
n an aqueous solution. Its longitudinal relaxivity
r1) is approximately 6 times greater than that of
d-DTPA chelates and more than twice that of
ther reported micelle and liposomal formulations
20). In preliminary studies, mesenchymal stem
ells labeled by GdFM were identified after injec-
ion into the brain of rats using CMR (21). GdFM eas also been used in pre-clinical imaging studies of
ymphatic tumor metastasis (22), characterization
f atherosclerotic plaques (23,24), characterization
f mammary tumors (25), assessment of nerve
egeneration (26), and labeling human monocytes
n vitro (27).
In the present study, we demonstrate the ability
o identify transplanted cells in the murine heart
sing GdFM with a perfluorinated Cy3 side chain
GdFM-Cy3). In vitro studies demonstrated that
dFM-Cy3 was easily transfectable, nontoxic,
tayed within cells after labeling, and could be
isualized using CMR and fluorescence micros-
opy. In vivo studies confirmed the efficacy of the
gent for the detection of cells transplanted into the
earts of mice with or without myocardial infarc-
ion. These findings indicate that GdFM-Cy3 is
promising agent for CMR-based cell-
racking studies.
E T H O D S
eneration and in vitro analysis of embryonic
tem cell cardiovascular progenitor cells
abeled with GdFM-Cy3. Murine ES cells
rom a CCE ES line (28) constitutively
xpressing green fluorescence protein
CCE-GFP) were maintained in serum-
ree medium supplemented with 1% LIF,
lutamine, and BMP4, were expanded on
elatinized culture plates until confluent,
nd then differentiated in the presence
f serum. Flk cells were isolated using
uorescence-activated cell sorting (FACS)
days after differentiation and cultured in
P-34 serum-free medium supplemented
ith the cytokines Dickopf, vascular en-
othelial growth factor, and fibroblast growth fac-
or. GdFM-Cy3 (5 mm) (Schering, Berlin, Ger-
any), prepared as previously published (19), was
dded to the culture on the 6th day of differentia-
ion. Twelve hours after adding GdFM-Cy3, cells
ere washed and placed back in serum-free me-
ium in the absence of GdFM-Cy3.
ES-CPC were kept in culture over a 14-day
eriod and periodically harvested. Inductively cou-
led plasma mass spectrometry (ICP-MS) was
erformed, and the concentration of GdFM-Cy3
er cell was calculated. To determine whether
dFM-Cy3 caused cell death, a colorimetric assay
as performed as originally described by Mosmann
29). To further assess for apoptosis after extended
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1116commercially available kit for the apoptosis-
pecific phospholipid binding protein Annexin V
BD Pharmingen, Franklin Lakes, New Jersey).
To evaluate whether GdFM-Cy3 can travel from
abeled cells into neighboring unlabeled cells, a
opulation of cells labeled with GdFM-Cy3 were
ombined with an equal number of ES-CPC from
line that constitutively expressed GFP. Flow
ytometry was performed 48 h later to assess for the
resence of GFP-positive Cy3-positive cells, indi-
ating the spread of GdFM-Cy3 into unlabeled
ells.
ell transplantation. Cell injection was performed in
evere combined immune deficiency (SCID) beige
ice, deficient in B, T, and NK cells. The hearts of
-month-old female SCID beige mice (Jackson
aboratories, Bar Harbor, Maine) were injected
ith either ES-CPC labeled with GdFM-Cy3
n  4) or unlabeled ES-CPC (n  4). Cells were
njected directly into the myocardium in a volume
f 7.5 l. A total of 500,000 cells were used per
njection, and 1 injection was performed per mouse.
o mortality was observed as a result of cell trans-
lant. These experiments were then repeated in
Figure 1. In Vitro Analysis of Cells Labeled With GdFM-Cy3
(A) Agarose gels containing 500,000 unlabeled, or 50,000, 100,000,
cardiac magnetic resonance. (B) A linear relationship between signa
with gadoﬂuorine M-Cy3 (GdFM-Cy3) imaged using ﬂuorescence m
stem cells constitutively expressing green ﬂuorescence protein (GFP
positive (D). Flow cytometry performed 48 h after coplating the cel
tion and a GFP-positive population (E). Also see accompanying Onlice with myocardial infarction using a coronary nigation model. After coronary ligation, intramyo-
ardial injection was performed using labeled ES-
PC (n 5) or unlabeled cells (n 6). Three mice
ied within 1 week of the post-operative period.
wo died immediately after surgery (1 from the cell
reatment group and 1 from the unlabeled cell
roup), and 1 was found dead 24 h after surgery
from the unlabeled cell group). This mortality rate
s consistent with the mortality rate of this surgery
n our laboratory’s experience. This resulted in a
otal of 4 infarcted mice from each surviving group.
n vitro CMR. To test the ability of CMR to detect
dFM-Cy3–labeled ES-CPC, agarose gels con-
aining labeled or unlabeled cells were imaged on a
.4-T dedicated mouse CMR scanner (Bruker In-
truments, Billerica, Massachusetts) equipped with
89-mm bore system operating at a proton fre-
uency of 400 MHz. All samples were prepared by
dding 0.2 ml of warm agarose gel to 1-ml tubes
ontaining 500,000, 300,000, 100,000, and 50,000
abeled ES-CPC.
n vivo imaging of infarcted mice. The in vivo detec-
ion of GdFM-Cy3–labeled ES-CPC was per-
ormed using a 9.4-T dedicated mouse CMR scan-
000, or 500,000 GdFM-Cy3–labeled cells were imaged with 9.4-T
-noise ratio (SNR) and cell number was observed. (C) Cells labeled
copy. (D and E) GdFM-Cy3–labeled cells coplated with embryonic
uorescence microscopy demonstrated that Cy3 cells were not GFP
monstrated 2 major populations, a GdFM-Cy3–positive popula-
ideo 1.300,
l-to
icros
). Fl
ls deer (Bruker Instruments) equipped with a 89-mm
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1117ore system operating at a proton frequency of 400
Hz. To identify and track the labeled cells over
ime, mice were imaged prior to transplantation, as
ell as 1, 7, and 14 days post-transplant. The
ongitudinal- and short-axis cine views of the heart
ere localized using scout scans in different planes.
ultiple images (n  10) throughout the cardiac
ycle resulted in the formation of a video that
llowed for the identification of GdFM-Cy3–
abeled cells moving within the myocardial wall.
he ability to follow the signal within the moving
yocardium allowed for the identification of the
abeled cells relative to coronary vessels that may
lso generate a positive signal on the T1-weighted
equence used.
MR images were analyzed by calculating the
ontrast-to-noise ratios (CNR) of hyperintense re-
ions (containing the GdFM-Cy3 ES-CPC) and
reas of normal myocardium (relative to the stan-
ard deviation of the noise). CNR analysis was
erformed using 4 mice from each group. Analysis
as performed in control mice (unlabeled ES-
PC) 2 weeks after injection, and in labeled mice
GdFM-Cy3–labeled cells) 1, 7, and 14 days post-
njection. Analysis was performed on both infarcted
nd noninfarcted animals, and the CNR between
dFM-Cy3–positive areas versus areas of the sur-
ounding myocardium were determined. The CNR
or each group is presented as mean  SD. The
egion of interest (ROI) size was kept constant at
.06 mm2 for each group. The statistical signifi-
ance of comparisons between all groups was deter-
ined using ANOVA analysis with a Tukey-
ramer multiple comparison post-test.
istology. Fluorescent immunohistochemistry was
sed for the detection and characterization of the
ransplanted GdFM-Cy3–labeled cells. Myocytes
ere identified using anti-mouse cTnT (Chemicon,
emicula, California) and anti-alpha-actinin
Sigma-Aldrich) was used to identify myocytes in
onjunction with the goat anti-mouse IgG alexa
uor 488 antibody (Invitrogen, Carlsbad, California).
API (Vectorlabs, Burlingame, California) was used
o stain all cell nuclei (blue).
E S U L T S
solation of ES-CPC and incubation with GdFM-
y3. Five days after plating the Flk population,
ynchronous waves of contracting cells could be
dentified across the entire plate and remained
eating throughout the study period. FACS analy-
is demonstrated that over 60% of cells expressed 0ardiac-specific troponin T (Online Fig. 1). Twelve
ours after labeling of GdFM-Cy3, red fluorescent
ells were seen using a fluorescence microscope
Fig. 1C) (Online Video 1). ICP-MS revealed that
1% of the GdFM-Cy3 added to the ES-CPC was
aken up by the cells.
CMR was performed on cell agarose gel phan-
oms containing 500,000, 300,000, 100,000, and
0,000 cells. The SNR values reflect the MR signal
btained for the number of cells homogeneously
istributed into a 0.2-ml volume. Given that the
nner diameter of the tubes used to construct the
hantoms was 5 mm and since each slice was
0
1000
2000
3000
4000
5000
6000
Ce
ll 
Nu
m
be
r
A
Control
**
GdFM
*
H2O2
0
20
40
60
80
100
1020 103 104 105
Annexin V
Ce
ll 
Co
un
t
B
GdFM Cells + H2O2
GdFM Cells
Unlabeled Cells
Figure 2. GdFM-Cy3 Toxicity Assays
(A) MTT assay. After 24 h, there was no difference in the num-
ber of live cells in both GdFM-Cy3–labeled and unlabeled popu-
lations of cardiovascular progenitor cells. *p  0.001 vs. control
and GdFM; **p  0.05 control and GdFM. (B) Annexin V expres-
sion measured using ﬂow cytometry. There was no difference in
the expression of Annexin V in labeled and unlabeled popula-
tions, whereas 16% of cells exposed to H2O2 for 2 h expressed
Annexin V. Abbreviation as in Figure 1..5-mm thick, the total number of cells in any given
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1118Figure 3. Evaluation of Noninfarcted Mice
T1-weighted high-resolution cardiac magnetic resonance (CMR) scan of noninfarcted mouse 1 day after injection (A). Longitudinal image indi-
cating position of axial slice (red line) in top frame. (B) Corresponding histology shows GdFM-Cy3 (red) within the myocardial wall, cardiac
Troponin T stain (green), and DAPI (blue), 5. (C) Frames 1 through 10 depict different frames within cardiac cycle. Red * indicates the right
ventricle and red ** indicates the left ventricle. Arrows show volume containing GdFM-Cy3 cells. Abbreviation as in Figure 1.Figure 4. Evaluation of Infarcted Mice
(A to D) A 9.4-T CMR was performed 1 day post-transplantation on mice injected with embryonic stem cell-cardiovascular progenitor cells
(ES-CPC) labeled with GdFM-Cy3 (A: long axis and C: short axis; red dotted line corresponds to location of short-axis image) or unlabeled ES-CPC
(B: long axis and D: short axis). An area of increased signal intensity was seen in short axis (yellow box, C). (E) Fluorescent microscopy on
frozen cardiac sections. Areas of Cy3-positive cells could be seen corresponding to blue and yellow boxes seen in A and C, respectively.
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1119.5mm slice is: 1,250, 750, 250, and 125 for
00,000, 300,000, 100,000, and 50,000 cells, re-
pectively (assumes homogeneous distribution of
ells). The results indicate a linear increase in SNR
ith increasing cell number, as shown in Figure
A. A total of 125 cells within a slice could be
asily identified by this method.
Cells labeled with GdFM-Cy3 were then
ocultured with ES-CPC from a line constitu-
ively expressing GFP. After 48 h of coincuba-
ion, the majority of cells were labeled with either
y3 or GFP, with only 4% of cells expressing
oth markers (Figs. 1D and 1E).
GdFM-Cy3 toxicity was assessed using MTT
nd Annexin assays. After 12 h of exposure, the
TT assay demonstrated that the viable cell
umber between treated (4,549  388) and
ntreated (4,771  447) populations was similar
p  0.05), in comparison to H2O2-treated cells
50  68) (p  0.001) (Fig. 2A). Fourteen days
fter labeling, apoptosis assays were done using
nnexin V. No difference in Annexin V was
etected between labeled and unlabeled groups
Fig. 2B). In addition, GdFM-Cy3–labeled cells
ontinued to spontaneously contract and were
asily identified by fluorescent microscopy (Online
ideo 1). Thus, we conclude that GdFM-Cy3
oes not affect cell survival or function in vitro.
n vivo studies. Positive MR signal enhancement
as clearly observed on both long- and short-axis
mages of the injected hearts. GdFM-Cy3 ES-
PC were identified in mice with and without
yocardial infarction, as shown in representative
mages in Figures 3 and 4. Positive MR signal
as noted in 3 to 4 contiguous short-axis images
n each animal injected. Signal was detected up to
week after transplantation in noninfarcted mice
nd up to 14 days in infarcted mice, but not in
egions containing unlabeled ES-CPC (Figs. 4B
nd 4D). Figure 5 shows images in a mouse with
n infarction obtained 24 h and 14 days after
ransplantation of GdFM-Cy3–lableled ES-
PC. Signal is clearly seen at both time points,
hough much more diffuse at the later time point.
To quantify signal enhancement, CNR values
ere calculated. In mice with myocardial infarc-
ions, CNR values of 0.21  0.01, 1.62  0.51,
nd 2.81  0.55 were observed in mice injected
ith unlabeled cells, GdFM-Cy3–labeled cells 1
ay post-transplant, and GdFM-Cy3–labeled
ells 14 days post-transplant, respectively (Fig.
). Additionally, the CNR values in noninfarcted
ice were 0.27  0.09, 1.67  0.33, and 1.06  w.17 in mice injected with unlabeled cells, mice
ith GdFM-Cy3–labeled cells after 1 day, and
ice with GDFM-Cy3–labeled cells after 14 days,
espectively (Fig. 6). The CNR values obtained
or all GdFM-Cy3 transplant groups were signif-
cantly greater than the values obtained for the
nlabeled control groups (p  0.001) at 1 day and
4 days post cell transplant. For the infarcted
roup, the CNR values increased from day 1 to
ay 14 by 73% (p  0.001). In noninfarcted mice,
o significant increases in CNR values were
bserved from day 1 to day 14. Instead, a signif-
cant decrease in CNR values (36%, p  0.001)
Figure 5. Serial Imaging of GdFM-Cy3–Labeled Cells Over Time
(A) A 9.4-T CMR performed 24 h after the injection of GdFM-
Cy3–labeled ES-CPC into a mouse with surgically induced myo-
cardial infarction. (B) A 9.4-T CMR performed in the same mouse
14 days after the injection of GdFM-Cy3 ES-CPC. Signiﬁcant
enhancement of the MR signal (arrows) in the anterior wall of
the left ventricle could be visualized. Abbreviations as in Figures
1 and 3.as observed. The CNR values obtained 14 days
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1120ost-transplant for the infarcted mice were 165%
reater than that observed for the noninfarcted
roup (p  0.001).
Microscopy revealed the presence of GdFM-
y3–positive cells in sections matching MR sig-
al enhancement, as shown in Figures 3 and 4.
y3-positive cells stained positive for alpha acti-
in and GFP, thereby indicating that GdFM-
y3 was present in the donor ES-CPC cell
opulation (Fig. 7). Cells were found in areas
oth proximal and within infarcted tissue.
I S C U S S I O N
he current study demonstrates the potential of
dFM-Cy3 for the detection of transplanted
S-CPC in the mouse myocardium. Phantom
maging using cells in agarose gels demonstrated
hat it is possible to detect as few as 125 cells per
.005 mm3 (Figs. 1A and 1B). The cellular
ptake of GdFM-Cy3 was effective (Figs. 1C to
E), and unlike ferromagnetic agents, did not
equire the use of transfection agents or other
ethods to promote labeling. Minimal migration
f the MR label was observed between the
dFM-Cy3–labeled cells (in vitro) and GFP-
xpressing control cells. These results indicate
imited cellular excretion and subsequent uptake
y neighboring cells within the time period
ested. This is critical for cell labels intended for
Control 1 Day 14 Days
Infarcted
Non-infarcted
Contrast-to-Noise Ratios
-noise ratios (CNR) calculated from infarcted and noninfarcted
ed with control (unlabeled cells) scanned at day 14 after injection
with GdFM-Cy3–labeled cells and scanned at day 1 and day 14.
isons are statistically signiﬁcant and have a p  0.001, except for
1 versus noninfarct day 14 (p  0.01), and infarct and nonin-
1 and control (p  0.05).racking, since cellular excretion/metabolism may lilute the MR signal observed. Previous work has
hown that the gadolinium label remains primar-
ly within the cytoplasmic compartment (without
ptake into lysosomes and/or endosomes),
hereby limiting metabolism and enabling effec-
ive MR signal enhancement (as observed both in
itro and in vivo) (22). In vitro work also suggests
hat ES-CPC may be safely labeled with GdFM-
y3 without affecting viability, as shown in
igure 2, or contractile function, as shown in
nline Video 1.
GdFM-Cy3 ES-CPC were clearly visualized
n the myocardium of mice after injection (Fig.
). A correspondence between the in vivo MR
mages and ex vivo fluorescence images (for Cy3)
as observed in all mice. Given that most cell
herapy will be performed in injured hearts, we
ncluded a cohort of mice with surgically induced
yocardial infarction (Figs. 4 and 5). Fourteen
ays after injection, no cells were noted by CMR
r histology in the noninfarct group. However, in
he infarcted mice, MR signal enhancement was
bserved over the entire 2-week time interval.
luorescent immunolabeling confirmed that post-
ransplant, the GdFM-Cy3 remained within trans-
lanted cells (Fig. 7). These findings suggest that
he milieu post-infarction may actually be more
upportive of cells in the long term than that of
he noninfarcted heart.
Quantitative evaluation of the MR data re-
ealed that the CNR values increase from 24 h to
4 days post-transplant. The reduced CNR at
arly time points is most likely related to T2*
ffects that may modulate and reduce the MR
ignal observed. As the cells diffuse or migrate as
function of time, the concentration of the MR
abel within a given volume is reduced, thereby
educing T2* effects and increasing the MR
ignal observed.
O N C L U S I O N S
dFM-Cy3 is a novel CMR contrast agent that
s easily taken up by ES-CPC in vitro, is retained
y these cells, and does not affect cell function or
urvival. Transplanted cells labeled with GdFM-
y3 can be identified in vivo and tracked using
1-weighted gradient echo CMR sequences. Al-
hough the current work is focused on the myo-
ardium, we believe GdFM-Cy3 may allow for0
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